• Title/Summary/Keyword: Digestive cancer

Search Result 391, Processing Time 0.027 seconds

Prediction of Fatal Radiation-Induced Cancer for Korean Using the BEIR V Method (BEIR V 방법을 이용한 한국인의 방사선에 의한 암사망 예측)

  • Hwang, Won-Tae;Han, Moon-Hee;Cho, Gyu-Seong
    • Journal of Radiation Protection and Research
    • /
    • v.21 no.3
    • /
    • pp.175-182
    • /
    • 1996
  • The lifetime fatal radiation-induced cancer for Korean has been estimated for both single and continuous radiation exposure using the BEIR V method. In case of single exposure, the major radiation-induced cancer type for young and old age is digestive and respiratory cancer, respectively. For the whole population of Korean, the major radiation-induced cancer type is digestive cancer. In case of 1mGy/yr continuous exposure from birth to death, the contribution of total radiation-induced cancer mortality to natural cancer mortality is about 3%.

  • PDF

Influence of Helicobacter pylori Infection on Endoscopic Findings of Gastric Adenocarcinoma of the Fundic Gland Type

  • Ishibashi, Fumiaki;Fukushima, Keita;Ito, Takashi;Kobayashi, Konomi;Tanaka, Ryu;Onizuka, Ryoichi
    • Journal of Gastric Cancer
    • /
    • v.19 no.2
    • /
    • pp.225-233
    • /
    • 2019
  • Purpose: Gastric adenocarcinoma of the fundic gland type (chief cell predominant type) (GA-FG-CCP) was first reported as a rare adenocarcinoma found in the normal fundic mucosa. Recent studies have proposed the possibility that GA-FG-CCPs were also generated in the atrophic mucosa after Helicobacter pylori (HP) eradication therapy. However, little is known on the endoscopic findings of GA-FG-CCP generated in the atrophic mucosa due to its extreme rarity. Materials and Methods: A total of 8 patients who underwent endoscopic submucosal resection and were diagnosed with GA-FG-CCP generated in the HP-uninfected mucosa (4 cases, HP-uninfected group) or HP-eradicated atrophic mucosa (4 cases, HP-eradicated group) were retrospectively analyzed, and their endoscopic findings, including magnifying endoscopy with narrow band imaging (M-NBI), and pathological features were compared. Results: While GA-FG-CCPs in the 2 groups displayed similar macroscopic appearance, M-NBI demonstrated that characteristic microvessels (tapered microvessels like withered branches) were specifically identified in the HP-eradicated group. Pathological investigation revealed that a decreasing number of fundic glands and thinned foveolar epithelium covering tumor ducts were thought to lower the thickness of the covering layer over tumor ducts in the HP-eradicated group. Moreover, dilation of vessels just under the surface of the lesions contributed to the visualization of microvessels by M-NBI. Conclusions: The change in background mucosa due to HP infection influenced the thickness of the covering layer over the tumor ducts and M-NBI finding of GA-FG-CCP.

Effect of Korean Red Ginseng on metabolic syndrome

  • Yoon, Sang Jun;Kim, Seul Ki;Lee, Na Young;Choi, Ye Rin;Kim, Hyeong Seob;Gupta, Haripriya;Youn, Gi Soo;Sung, Hotaik;Shin, Min Jea;Suk, Ki Tae
    • Journal of Ginseng Research
    • /
    • v.45 no.3
    • /
    • pp.380-389
    • /
    • 2021
  • Metabolic syndrome (MS) refers to a clustering of at least three of the following medical conditions: high blood pressure, abdominal obesity, hyperglycemia, low high-density lipoprotein level, and high serum triglycerides. MS is related to a wide range of diseases which includes obesity, diabetes, insulin resistance, cardiovascular disease, dyslipidemia, or non-alcoholic fatty liver disease. There remains an ongoing need for improved treatment strategies for MS. The most important risk factors are dietary pattern, genetics, old age, lack of exercise, disrupted biology, medication usage, and excessive alcohol consumption, but pathophysiology of MS has not been completely identified. Korean Red Ginseng (KRG) refers to steamed/dried ginseng, traditionally associated with beneficial effects such as anti-inflammation, anti-fatigue, anti-obesity, anti-oxidant, and anti-cancer effects. KRG has been often used in traditional medicine to treat multiple metabolic conditions. This paper summarizes the effects of KRG in MS and related diseases such as obesity, cardiovascular disease, insulin resistance, diabetes, dyslipidemia, or non-alcoholic fatty liver disease based on experimental research and clinical studies.

Endoscopic Diagnosis, Treatment, and Follow-up of Serrated Polyps (톱니상 폴립의 내시경적 진단, 치료와 추적 관리)

  • Duk Hwan Kim
    • Journal of Digestive Cancer Research
    • /
    • v.11 no.1
    • /
    • pp.30-34
    • /
    • 2023
  • Since the 1990s, serrated polyps have been established to contribute to intermediate cancer development, and their importance has begun to be recognized. Serrated polyps are morphologically difficult to detect through endoscopy, and an effective resection method has not been established. Among serrated polyps, studies on sessile serrated lesions, with a relatively high risk of colorectal cancer transformation and detected with difficulty, are in progress. Studies to date describe the endoscopic features as mucus cap, surface debris or stool, attenuation of underlying vasculature, cloud-like surface, dark spots in crypts, and ill-defined irregular border. Additionally, it is expected that relatively large serrated polyps can be safely removed through cold snare resection. A plan for an effective management of serrated polyps through continuous research in the future is warranted.

The Metformin Use and Gastric Cancer Risk (메트포르민의 사용과 위암 발생)

  • Kim, Young-Il
    • Journal of Digestive Cancer Research
    • /
    • v.8 no.2
    • /
    • pp.97-101
    • /
    • 2020
  • Metformin is a widely used first-line anti-diabetic drug worldwide. Epidemiologic studies using the large population-based cohort database have shown the association between metformin uses and reduced risk of various type cancers including gastric cancer. In the gastric cancer prevention, metformin use was associated with the significant reduction of gastric cancer risk, especially for long-term metformin users. However, there is no well-designed randomized controlled clinical trial investigating the effect of metformin as a chemopreventive drug for gastric cancer. Therefore, further well-designed clinical trials will be needed to implement metformin for chemoprevention of gastric cancer.